Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S-K Herukka

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Acta Paediatrica (Oslo, Norway : 1992)|April 27, 2026
Elevated Serum Neurofilament Light Chain Is Associated With Systemic Inflammation in Very Preterm InfantsE-V Kivivuori, S-K Herukka, S Kärkkäinen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 19, 2010
Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort studyT T Seppälä, S-K Herukka, T Hänninen, et al.
Neurobiology of Aging|January 24, 2007
Genetic study evaluating LDLR polymorphisms and Alzheimer's diseaseR Lämsä, S Helisalmi, S-K Herukka, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 19, 2007
The association study between DHCR24 polymorphisms and Alzheimer's diseaseR Lämsä, S Helisalmi, M Hiltunen, et al.
Dementia and Geriatric Cognitive Disorders|July 12, 2007
Study on the association between SOAT1 polymorphisms, Alzheimer's disease risk and the level of CSF biomarkersR Lamsa, S Helisalmi, S-K Herukka, et al.
Dementia and Geriatric Cognitive Disorders|October 22, 2008
PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairmentJ Koivunen, T Pirttilä, N Kemppainen, et al.
Translational Psychiatry|July 27, 2012
Metabolome in progression to Alzheimer's diseaseM Orešič, T Hyötyläinen, S-K Herukka, et al.
Neurology|April 21, 2012
CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findingsT T Seppälä, O Nerg, A M Koivisto, et al.
European Journal of Neurology|October 9, 2020
Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalusM Nakajima, T Rauramaa, P M Mäkinen, et al.
Neurology|February 4, 2012
Age and diagnostic performance of Alzheimer disease CSF biomarkersN Mattsson, E Rosén, O Hansson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Acta Paediatrica (Oslo, Norway : 1992)|April 27, 2026
Elevated Serum Neurofilament Light Chain Is Associated With Systemic Inflammation in Very Preterm InfantsE-V Kivivuori, S-K Herukka, S Kärkkäinen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 19, 2010
Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort studyT T Seppälä, S-K Herukka, T Hänninen, et al.
Neurobiology of Aging|January 24, 2007
Genetic study evaluating LDLR polymorphisms and Alzheimer's diseaseR Lämsä, S Helisalmi, S-K Herukka, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 19, 2007
The association study between DHCR24 polymorphisms and Alzheimer's diseaseR Lämsä, S Helisalmi, M Hiltunen, et al.
Dementia and Geriatric Cognitive Disorders|July 12, 2007
Study on the association between SOAT1 polymorphisms, Alzheimer's disease risk and the level of CSF biomarkersR Lamsa, S Helisalmi, S-K Herukka, et al.
Dementia and Geriatric Cognitive Disorders|October 22, 2008
PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairmentJ Koivunen, T Pirttilä, N Kemppainen, et al.
Translational Psychiatry|July 27, 2012
Metabolome in progression to Alzheimer's diseaseM Orešič, T Hyötyläinen, S-K Herukka, et al.
Neurology|April 21, 2012
CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findingsT T Seppälä, O Nerg, A M Koivisto, et al.
European Journal of Neurology|October 9, 2020
Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalusM Nakajima, T Rauramaa, P M Mäkinen, et al.
Neurology|February 4, 2012
Age and diagnostic performance of Alzheimer disease CSF biomarkersN Mattsson, E Rosén, O Hansson, et al.
Pageof 1